Neural stem cell‐based therapies and glioblastoma management: Current evidence and clinical challenges
Autor
Benmelouka, Amira Yasmine
Munir, Malak
Sayed, Ahmed
Salah Attia, Mohamed
Ali, Mohamed Mahmoud
Negida, Ahmed
Ali Alghamdi, Badrah Saeed
Kamal, Mohammad Amjad
Barreto, George E.
Md Ashraf, Ghulam
Meshref, Mostafa
Bahbah, Eshak I.
Resumen
Gliomas, which account for nearly a quarter of all primary CNS tumors, present significant contemporary therapeutic challenges, particularly the highest‐grade variant (glioblastoma multiforme), which has an especially poor prognosis. These difficulties are due to the tumorʹs aggressiveness and the adverse effects of radio/chemotherapy on the brain. Stem cell therapy is an exciting area of research being explored for several medical issues. Neural stem cells, normally present in the subventricular zone and the hippocampus, preferentially migrate to tumor masses. Thus, they have two main advantages: They can minimize the side effects associated with systemic ra-dio/chemotherapy while simultaneously maximizing drug delivery to the tumor site. Another fea-ture of stem cell therapy is the variety of treatment approaches it allows. Stem cells can be genetically engineered into expressing a wide variety of immunomodulatory substances that can inhibit tumor growth. They can also be used as delivery vehicles for oncolytic viral vectors, which can then be used to combat the tumorous mass. An alternative approach would be to combine stem cells with prodrugs, which can subsequently convert them into the active form upon migration to the tumor mass. As with any therapeutic modality still in its infancy, much of the research regarding their use is primarily based upon knowledge gained from animal studies, and a number of ongoing clinical trials are currently investigating their effectiveness in humans. The aim of this review is to highlight the current state of stem cell therapy in the treatment of gliomas, exploring the different mechanistic approaches, clinical applicability, and the existing limitations.
Colecciones
Ítems relacionados
Mostrando ítems relacionados por Título, autor o materia.
-
Article
Global investments in pandemic preparedness and COVID-19: development assistance and domestic spending on health between 1990 and 2026 (2024)
Micah, Angela E.; Bhangdia, Kayleigh; Cogswell, Ian E.; Lasher, Dylan; Lidral-Porter, Brendan; Maddison, Emilie R.; Nguyen, Trang Nhu Ngoc; Patel, Nishali; Pedroza, Paola; Solorio, Juan; ... (Elsevier Ltd, 2023)Background: The COVID-19 pandemic highlighted gaps in health surveillance systems, disease prevention, and treatment globally. Among the many factors that might have led to these gaps is the issue of the financing of ... -
Article
Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021 (2024)
Ong, Kanyin Liane; Stafford, Lauryn K.; McLaughlin, Susan A.; Boyko, Edward J.; Vollset, Stein Emil; Smith, Amanda E.; Dalton, Bronte E.; Duprey, Joe; Cruz, Jessica A.; Hagins, Hailey; ... (Elsevier B.V., 2023)Background: Diabetes is one of the leading causes of death and disability worldwide, and affects people regardless of country, age group, or sex. Using the most recent evidentiary and analytical framework from the Global ... -
Review
Peptide based therapeutics and their use for the treatment of neurodegenerative and other diseases (2020)
Baig M.H.; Ahmad K.; Saeed M.; Alharbi A.M.; Barreto G.E.; Ashraf G.M.; Choi I. (Elsevier Masson SAS, 2018)